Ledger.Open graph →

SEC Form D · filed July 12, 2019

Akari Therapeutics Plc

Offering

$4.5M

Sold

$4.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

LONDON, United Kingdom

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Aike Ho · Oakland, CADirector Eric Wiesen · Oakland, CADirector Gerard Cuddy · Irvine, CADirector Jeffrey Zhao · West Hollywood, CADirector Eslie C. Sykes · Raleigh, NCExec · Director Peter Feldschreiber · London, United KingdomDirector Sara Y. Huda · Grand Duchy of Luxembourg, LuxembourgExec · Director Jeffrey O'Donohue · TOLUCA LAKE, CADirector Dov Elefant · New York, NYExec · Director Mariel A. Joliet · HOUSTON, TXDirector George E. Marucci, Jr · HOUSTON, TXDirector Susan C. Schnabel · HOUSTON, TXDirector Douglas L. Goodwillie · HOUSTON, TXDirector Kenneth B. Leonard · HOUSTON, TXExec · Director Terry A. Hart · HOUSTON, TXDirector Michael J. O'Neil · HOUSTON, TXExec · Director John B. Riley · HOUSTON, TXDirector Dov Elefant · London, United KingdomExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗